Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
NEW YORK (Reuters Health) – Patients with previously untreated multiple myeloma do better when they are given an autologous stem-cell transplant followed by an allogeneic transplant from a…
NEW YORK (Reuters Health) – Among older women with breast cancer, specific comorbid conditions are independently associated with decreased survival, according to a report in the Journal of…
NEW YORK (Reuters Health) – Argon plasma coagulation (APC) in combination with another method of esophageal recanalization is better than APC alone as palliative therapy in patients with…
NEW YORK (Reuters Health) – Venous thromboembolism (VTE) after colorectal surgery is nearly twice as common when a patient undergoes an open procedure compared to laparoscopy, a study…
NEW YORK (Reuters Health) – While angiotensin receptor blockers (ARBs) as a class do not appear to be associated with an increased malignancy risk in patients with diabetes,…
NEW YORK (Reuters Health) – Some patients with metastatic clear-cell renal cancer appear to fare relatively well when treated with sunitinib before undergoing planned nephrectomy — even though…
NEW YORK (Reuters Health) – Using intra-arterial chemotherapy to treat retinoblastoma can produce a “dramatic response,” but also comes with the risk of both mild and severe side…
NEW YORK (Reuters Health) – Women who are positive for human papilloma virus (HPV) and have low-grade cervical cytological abnormalities but normal colposcopic findings are at low risk…
NEW YORK (Reuters Health) – While partial nephrectomy remains the gold standard for treatment of small renal masses, laparoscopic cryoablation is a good option for selected patients, an…
NEW YORK (Reuters Health) – Hysteroscopy using narrow-band imaging (NBI) technology may be more sensitive than white-light imaging (WLI) for diagnosing endometrial cancer and hyperplasia, hint results of…
